Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Equity Ratio: 2016-2024

Historic Equity Ratio for Akebia Therapeutics (AKBA) over the last 9 years, with Dec 2024 value amounting to -0.22.

  • Akebia Therapeutics' Equity Ratio rose 146.94% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year increase of 146.94%. This contributed to the annual value of -0.22 for FY2024, which is 76.15% down from last year.
  • As of FY2024, Akebia Therapeutics' Equity Ratio stood at -0.22, which was down 76.15% from -0.13 recorded in FY2023.
  • Akebia Therapeutics' 5-year Equity Ratio high stood at 0.38 for FY2020, and its period low was -0.22 during FY2024.
  • Over the past 3 years, Akebia Therapeutics' median Equity Ratio value was -0.13 (recorded in 2023), while the average stood at -0.11.
  • Data for Akebia Therapeutics' Equity Ratio shows a maximum YoY slumped of 961.44% (in 2023) over the last 5 years.
  • Akebia Therapeutics' Equity Ratio (Yearly) stood at 0.38 in 2020, then crashed by 63.14% to 0.14 in 2021, then crashed by 89.49% to 0.01 in 2022, then tumbled by 961.44% to -0.13 in 2023, then tumbled by 76.15% to -0.22 in 2024.